Wedbush analyst Laura Chico maintains Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $218 to $247.
Boeing Wants To Make Flying Cars In Asia While Aircraft Unit Faces Severe Turbulence
Boeing recently opened a new research and development base in the Japanese city of Nagoya, its seventh such facility outside the U.S.
